| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a Day
EDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that Clara—an early patient treated with the Company's patented OneRF® Ablation System—has successfully surpassed the one year milestone of being seizure free.
Clara was one of the first patients to undergo treatment using NeuroOne's OneRF® platform. Since the procedure in June 2024, Clara has been completely seizure-free, which has greatly improved her quality of life.
Posted In: NMTC
